Literature DB >> 24630288

Does the co-occurrence of FGFR3 gene mutation in hypochondroplasia, medial temporal lobe dysgenesis, and focal epilepsy suggest a syndrome?

Antonino Romeo1, Monica Lodi2, Maurizio Viri2, Eliana Parente2, Maurizia Baldi3, Andrea Righini4, Donatella Milani5.   

Abstract

BACKGROUND: Hypochondroplasia is a rare skeletal dysplasia characterized by disproportionately short stature, lumbar lordosis, and limited extension of the elbow caused by mutations in the fibroblast growth factor receptor 3 (FGFR3) gene that plays a role in controlling nervous system development. Hypochondroplasia with FGFR3 mutation associated with bilateral medial temporal lobe anomalies and focal epilepsy was previously reported in several patients. PATIENT: We report clinical, electroclinical, and neuroradiological findings of one patient affected by hypochondroplasia.
RESULTS: Clinical diagnosis was confirmed by molecular analysis of the FGFR3 gene, which showed a N540 K mutation. The patient had normal psychomotor development and showed early-onset focal seizures with left temporal localization on interictal and ictal electroencephalograph. The seizures were well controlled, and the patient has been seizure-free since infancy. Magnetic resonance imaging showed abnormal anteriorly posteriorly infolding in the hippocampus and abnormally oriented parahippocampus sulci, and additional cortical rim dysplasia with gray-white matter junction blurring in the hippocampus.
CONCLUSIONS: The present case of hypochondroplasia and FGFR3 mutation in Asn540Lys associated with characteristic abnormalities involving bilaterally medial temporal lobe structures, probable hippocampal cortex focal dysplasia, and early onset of focal epilepsy underscores the possibility of a rare syndrome.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FGFR3 gene; Hypochondroplasia; focal dysplasia; focal temporal epilepsy; hippocampus abnormalities; medial temporal lobe dysgenesis

Mesh:

Substances:

Year:  2014        PMID: 24630288     DOI: 10.1016/j.pediatrneurol.2014.01.004

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  4 in total

1.  Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions.

Authors:  Anna Luisa Di Stefano; Alberto Picca; Edouard Saragoussi; Franck Bielle; Francois Ducray; Chiara Villa; Marica Eoli; Rosina Paterra; Luisa Bellu; Bertrand Mathon; Laurent Capelle; Véronique Bourg; Arnaud Gloaguen; Cathy Philippe; Vincent Frouin; Yohann Schmitt; Julie Lerond; Julie Leclerc; Anna Lasorella; Antonio Iavarone; Karima Mokhtari; Julien Savatovsky; Agusti Alentorn; Marc Sanson
Journal:  Neuro Oncol       Date:  2020-11-26       Impact factor: 12.300

2.  Clinical and Radiologic Evaluation of an Individual with Hypochondroplasia and a Novel FGFR3 Mutation.

Authors:  Rosario Ramos Mejía; Miriam Aza-Carmona; Mariana Del Pino; Karen E Heath; Virginia Fano; Maria Gabriela Obregon
Journal:  J Pediatr Genet       Date:  2019-09-02

3.  Novel phenotype of achondroplasia due to biallelic FGFR3 pathogenic variants.

Authors:  Irene J Chang; Angela Sun; Maryse L Bouchard; Shawn E Kamps; Susan Hale; Stephen Done; Michael J Goldberg; Ian A Glass
Journal:  Am J Med Genet A       Date:  2018-07       Impact factor: 2.802

4.  CircHivep2 contributes to microglia activation and inflammation via miR-181a-5p/SOCS2 signalling in mice with kainic acid-induced epileptic seizures.

Authors:  Gao Xiaoying; Mian Guo; Liu Jie; Zhu Yanmei; Cui Ying; Shu Shengjie; Gou Haiyan; Sun Feixiang; Qi Sihua; Sun Jiahang
Journal:  J Cell Mol Med       Date:  2020-10-01       Impact factor: 5.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.